Inflammatory Complications in Chronic Granulomatous Disease

Area of Science:

• Immunology
• Genetics
• Inflammation Research

Background:

• Chronic granulomatous disease (CGD) is a rare primary immunodeficiency disorder.
• CGD typically presents with recurrent severe infections.
• Inflammatory complications are also frequent in CGD, affecting various organ systems.

Purpose of the Study:

• To review the inflammatory complications of Chronic Granulomatous Disease (CGD).
• To explore the underlying pathogenetic mechanisms of CGD-related inflammation.
• To discuss current and emerging therapeutic strategies for managing these complications.

Main Methods:

• Review of existing literature on CGD pathogenesis and clinical manifestations.
• Analysis of the role of neutrophil function and residual oxidase activity in disease phenotype.
• Evaluation of therapeutic approaches for inflammatory complications in CGD.

Main Results:

• Inflammatory complications in CGD affect gastrointestinal, respiratory, and urinary tracts, among others.
• Mechanisms are multifactorial, involving host response to infection and varying levels of neutrophil oxidative burst.
• Traditional immunosuppressants are often contraindicated due to infection risk.

Conclusions:

• Novel targeted therapies including anti-TNFa agents, anakinra, ustekinumab, and vedolizumab represent promising treatment options.
• Hematopoietic stem cell transplantation is a potential curative option for severe CGD cases.
• Further research into CGD pathogenesis is needed to optimize management of inflammatory sequelae.